David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Nucor
NUE
$56B
| $854K | ﹤0.01% |
13,667
-357,732
| -96% | -$22.8M |
|
2752
TIM SA
TIMB
$8.5B
| $851K | ﹤0.01% |
+50,463
| New | +$990K |
|
2753
MediciNova
MNOV
$77.3M
| $850K | ﹤0.01% |
107,890
+72,982
| +209% | +$755K |
|
2754
LSI Industries
LYTS
$747M
| $847K | ﹤0.01% |
158,550
+39,356
| +33% | +$239K |
|
|
SINA
2755
CALL
DELISTED
Sina Corp
SINA
| $847K | ﹤0.01% |
10,000
| – | – |
|
2756
Acacia Research
ACTG
$442M
| $846K | ﹤0.01% |
203,750
+42,838
| +27% | +$165K |
|
2757
Monarch Casino & Resort
MCRI
$2.22B
| $846K | ﹤0.01% |
19,207
-10,289
| -35% | -$453K |
|
|
AMWD
2758
DELISTED
American Woodmark
AMWD
| $845K | ﹤0.01% |
+9,235
| New | +$853K |
|
2759
Talphera
TLPH
$62.3M
| $844K | ﹤0.01% |
12,500
+4,409
| +54% | +$262K |
|
|
PEGI
2760
PUT
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $844K | ﹤0.01% |
45,000
-4,400
| -9% | -$80.1K |
|
|
QADA
2761
DELISTED
QAD Inc.
QADA
| $843K | ﹤0.01% |
16,813
+7,151
| +74% | +$344K |
|
2762
Amphenol
APH
$195B
| $842K | ﹤0.01% |
38,636
-81,636
| -68% | -$1.78M |
|
2763
CALL
US Bancorp
USB
$97B
| $840K | ﹤0.01% |
+16,800
| New | +$853K |
|
2764
CALL
Verisk Analytics
VRSK
$25B
| $840K | ﹤0.01% |
+7,800
| New | +$830K |
|
|
ICPT
2765
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $839K | ﹤0.01% |
10,000
| – | – |
|
|
DO
2766
CALL
DELISTED
Diamond Offshore Drilling
DO
| $834K | ﹤0.01% |
+40,000
| New | +$745K |
|
2767
Axogen
AXGN
$2.67B
| $830K | ﹤0.01% |
16,519
+4,623
| +39% | +$204K |
|
2768
PUT
Dine Brands
DIN
$444M
| $830K | ﹤0.01% |
11,100
-4,000
| -26% | -$289K |
|
2769
PUT
Ingredion
INGR
$6.6B
| $830K | ﹤0.01% |
7,500
+4,100
| +121% | +$482K |
|
2770
Community Bank
CBU
$3.32B
| $829K | ﹤0.01% |
+14,034
| New | +$819K |
|
2771
InflaRx
IFRX
$307M
| $828K | ﹤0.01% |
+25,660
| New | +$886K |
|
2772
Prothena Corp
PRTA
$494M
| $825K | ﹤0.01% |
56,586
-6,358
| -10% | -$126K |
|
2773
CALL
Warner Bros
WBD
$72.2B
| $825K | ﹤0.01% |
30,000
| – | – |
|
2774
Theravance Biopharma
TBPH
$883M
| $821K | ﹤0.01% |
36,178
-36,691
| -50% | -$871K |
|
2775
TriCo Bancshares
TCBK
$1.73B
| $820K | ﹤0.01% |
21,896
+10,451
| +91% | +$400K |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.